TruCBN™
Medicare BEI Program
About Us
Resources
TruCBN™
The Info Sheet
Concise overview of TruCBN™: clinical data, GLP safety package, dosing, formats, and regulatory status.
The Sleep Study
Peer-reviewed, placebo-controlled study in 1,020 adults showing 50 mg TruCBN™ improves sleep quality.
The Real World Evidence Study
29-day real-world study tracking 164 adults on TruCBN™: longer sleep, fewer wakings, better mornings.
The CBN Brain Study
Peer-reviewed preclinical study showing CBN improves memory and mitochondrial health in an accelerated aging model.
Request a Sample of TruCBN™
Free TruCBN™ sample shipped to qualified brands for formulation and testing.
Hemp in Medicare
Hemp in Medicare: The BEI Playbook
Step-by-step guide for hemp brands entering Medicare's new federal cannabinoid channel.
The TruCBN™ Medicare Memorandum
Clinical evaluation memo for ACOs assessing TruCBN™ under the CMS Substance Access BEI program.
Knowledge Center
Minor Cannabinoid Market Report
Sales data from 10 cannabis markets showing $132M in minor cannabinoid revenue and what's next.
THCV Simplified
Plain-English primer on THCV: science, formulation notes, and market potential for energy and focus products.
Featured
Hemp in Medicare: The BEI Playbook
Medicare opened its first federal channel for hemp-derived cannabinoid products in April 2026. This playbook walks hemp brands through what the BEI program is, what it takes to get a product accepted, and how TruCBN™ fits.
Get the Playbook
News
Contact Us
Technology
Academic Collaboration
Formulation Kit
Wholesale Ingredients
Retail Products
Wholesale Ingredients
Download the CBN Brain Health Study
New research showing how CBN improved spatial learning, memory, and mitochondrial health in an accelerated aging model.
